This syndrome is characterized by clinical symptoms of sickness behavior such as leaden paralysis of the limbs, hypersomnia, and hyperphagia/weight gain, while mood reactivity is unimpaired, i.e., mood brightens in response to positive events (according to DSM-5 criteria for MDD with atypical features), while still suffering from lack of concentration and higher levels of exhaustibility as in melancholic MDD [99]
Gastrointestinal side effects drive many medication switches
This peptide has achieved an average of 15% body weight loss in clinical trials, far surpassing older weight loss medications
All these factors are responsible for the impairment of RBC membrane structure in patients with CKD [260]
Cardiologists are invited to be more familiar with the members of this pharmacological family
Many people find relief with less invasive options